Physician profile

Monica M Grova

Hematology & Oncology · Burlingame, CA

NPI 1265866487

$8,775.74

in general payments reported to CMS, 2019-2025

8 companies · $7.92 in 2025

See the full distribution for Hematology & Oncology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$1,000.00
Food and Beverage$337.13

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $8,283.05 2021-2025 Davinci Xi, Da Vinci Surgical System
W. L. Gore & Associates, INC. $137.92 2019
Abbvie INC. $125.00 2024
Baxter Healthcare $86.06 2019
Medtronic, INC. $76.89 2023
Stryker Corporation $24.18 2023 Spy-Phi System
Merck Sharp & Dohme LLC $22.04 2024 Bridion
Ethicon US, LLC $20.60 2024 Echelon Circular, Contour, Echelon Flex

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Monica M Grova

$8,775.74

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/5581828/monica-m-grova

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.